Hence, dysregulation of MAM proteins underlies various clinical conditions, including neurodegenerative diseases [14], obesity, type 2 diabetes mellitus (T2DM) [15], cardiomyopathy [16], and cancer [17]. Here, SGCG is linked to obesity due to melanocortin 4 receptor deficiency.